Is "watch-and-wait" after chemoradiotherapy safe in patients with rectal cancer?
What you need to know: After standard long-course chemoradiotherapy for locally advanced rectal cancer, up to a quarter of patients have no clinically apparent tumour—referred to as a clinical complete response. Evidence from observational studies suggests these patients can be considered for a “wat...
Gespeichert in:
Veröffentlicht in: | BMJ (Online) 2018-11, Vol.363, p.k4472-k4472 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | What you need to know: After standard long-course chemoradiotherapy for locally advanced rectal cancer, up to a quarter of patients have no clinically apparent tumour—referred to as a clinical complete response. Evidence from observational studies suggests these patients can be considered for a “watch-and-wait” approach with regular surveillance to avoid major surgery. Up to a third of patients on a watch-and-wait programme develop tumour regrowth and require salvage surgery; the long term outcomes are uncertain. |
---|---|
ISSN: | 0959-8138 1756-1833 |
DOI: | 10.1136/bmj.k4472 |